You are currently viewing a new version of our website. To view the old version click .

Hemato, Volume 2, Issue 3

September 2021 - 15 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (15)

  • Article
  • Open Access
11 Citations
5,189 Views
22 Pages

CAR-T Cell Therapy for the Treatment of ALL: Eradication Conditions and In Silico Experimentation

  • Paul A. Valle,
  • Luis N. Coria,
  • Corina Plata and
  • Yolocuauhtli Salazar

18 July 2021

In this paper, we explore the application of Chimeric Antigen Receptor (CAR) T cell therapy for the treatment of Acute Lymphocytic Leukaemia (ALL) by means of in silico experimentation, mathematical modelling through first-order Ordinary Differential...

  • Review
  • Open Access
4,787 Views
12 Pages

13 July 2021

We reviewed our studies on epidemiology and germline genetics of amyloidosis. In epidemiology, we considered both hereditary and non-hereditary amyloidosis. As the source of data, we used the nationwide Swedish hospital discharge register. We estimat...

  • Review
  • Open Access
3 Citations
6,330 Views
26 Pages

Chronic Myelomonocytic Leukemia Gold Jubilee

  • Eric Solary and
  • Raphael Itzykson

1 July 2021

Chronic myelomonocytic leukemia (CMML) was named 50 years ago to describe a myeloid malignancy whose onset is typically insidious. This disease is now classified by the World Health Organisation as a myelodysplastic syndrome (MDS)-myeloproliferative...

  • Feature Paper
  • Review
  • Open Access
2 Citations
4,304 Views
11 Pages

30 June 2021

Patients with myeloproliferative neoplasm (MPN) are potentially facing diminished life expectancy and decreased quality of life, due to thromboembolic and hemorrhagic complications, progression to myelofibrosis or acute leukemia with ensuing signs of...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Hemato - ISSN 2673-6357